Key facts
- Elo Life Systems’s last known valuation is $74.5M (Jan 2024).
- It has raised $45.0M across 2 recorded rounds; the latest was Early Stage VC ($5.4M) in Jan 2026.
- Notable investors include Alexandria Venture Investments, Novo Holdings, Hanwha Asset Management (USA), DCVC Bio, Accelr8 (Impact Fund Investing) — 8 tracked in total.
- Elo Life Systems has filed 1 Form D with the SEC, most recently Jan 2024 ($10.3M sold to 14 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Elo Life Systems
Funding rounds
2 roundsAbout Elo Life Systems
Producer of plant-based food ingredients designed to enhance taste, health attributes, and climate resilience in consumer food products. The company develops novel functional sweeteners and crop-derived ingredients using advanced plant science and biotechnology, focusing on reducing sugar while maintaining taste, improving nutritional profiles, increasing resilience of key crops to disease and climate stress, enabling food and beverage manufacturers to create scalable, label-friendly products with lower environmental impact and more sustainable supply chains.
- Sector
- Business Products and Services (B2B)
- HQ
- Durham, NC, United States
- Founded
- 2021
- Employees
- 30
- Website
- elolife.com/
- Ownership
- Privately Held (backing)
Elo Life Systems doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Elo Life Systems shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Elo Life Systems in its N-PORT filings yet. We sweep new filings monthly.